MD MBA - Kalvista Pharmaceuticals Chief Officer

Kalvista Pharmaceuticals Management Efficiency

The company has return on total asset (ROA) of (0.5394) % which means that it has lost $0.5394 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9084) %, meaning that it created substantial loss on money invested by shareholders. Kalvista Pharmaceuticals' management efficiency ratios could be used to measure how well Kalvista Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Kalvista Pharmaceuticals' Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to climb to 0.16 in 2024, whereas Return On Tangible Assets are likely to drop (1.09) in 2024. At this time, Kalvista Pharmaceuticals' Non Current Assets Total are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 1 M in 2024, whereas Other Current Assets are likely to drop slightly above 1 M in 2024.

Similar Executives

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME sebetralstat, which is initiation of the Phase 3 KONFIDENT trial as a potential oral, on-demand therapy for HAE attacks KVD824, an oral product candidate for the treatment of HAE and Factor XIIa, an oral inhibitor program which is in preclinical stage targets an enzyme in HAE. Kalvista Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 105 people. Kalvista Pharmaceuticals (KALV) is traded on NASDAQ Exchange in USA. It is located in 55 Cambridge Parkway, Cambridge, MA, United States, 02142 and employs 150 people. Kalvista Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Kalvista Pharmaceuticals Leadership Team

Kalvista Stock Performance Indicators

Additional Tools for Kalvista Stock Analysis